Dan and Axios' Sara Fischer dig into why the White House didn't join global call to curb terrorist and other extremist online content, instead launching a solo effort focused on political bias.
Go deeper: Sara's piece on the White House's decision not to sign the Christchurch pact
Photo: Olivier Douliery/AFP via Getty Images
Gilead Sciences CEO Daniel O’Day said in an open letter Saturday the company is expanding access to its experimental anti-coronavirus drug remdesivir to include severely ill COVID-19 patients.
The big pig picture: President Trump has called the antiviral drug "promising," but the results of six clinical trials on this investigational medicine are still being conducted, so its effectiveness in COVID-19 the treatment has yet to be proved. The World Health Organization is involved in the tests.
Illustration: Sarah Grillo/Axios
Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.
The novel coronavirus has now killed more than 30,000 people around the world — with Italy reporting over 10,000 deaths, per Johns Hopkins data.
The big picture: The number of deaths from COVID-19 in the U.S. surpassed 2,000 on Saturday. The United States leads the world in confirmed coronavirus infections — more than 124,000 by late Saturday. The number of those recovered from the virus in the U.S. passed the 1,000-mark on Saturday evening.